Low Prostate-specific Antigen and No Gleason Score Upgrade Despite More Extensive Cancer During Active Surveillance Predicts Insignificant Prostate Cancer at Radical Prostatectomy
Authors:
- Adam D. TollATAdam D. Toll
- Ali AminAAAli Amin
- H. Ballentine CarterHCH. Ballentine Carter
- Patricia LandisPLPatricia Landis
- Stephen LeeSLStephen Lee
- Jonathan I. EpsteinJEJonathan I. Epstein
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Contemporary Concept of Significant Versus Insignificant Prostate CancerEuropean Urology, 2011
- Prostate Cancer Staging and Grading at Radical Prostatectomy Over TimeAdvances in Anatomic Pathology, 2011
- Predicting 15-Year Prostate Cancer Specific Mortality After Radical ProstatectomyJournal of Urology, 2011
- Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate CancerJournal of Clinical Oncology, 2011
- Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up StudyJNCI: Journal of the National Cancer Institute, 2010
- Prospective Study of Determinants and Outcomes of Deferred Treatment or Watchful Waiting Among Men With Prostate Cancer in a Nationwide CohortJournal of Clinical Oncology, 2009
- The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): Design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancerContemporary Clinical Trials, 2009
- A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survivalBritish Journal of Cancer, 2006
- Gleason grading and prognostic factors in carcinoma of the prostateLaboratory Investigation, 2004
- Increasing Incidence of Minimal Residual Cancer In Radical Prostatectomy SpecimensAmerican Journal of Surgical Pathology, 1997